TOC 2025

• Introduction
• Innovative Medicines Canada Guidelines for Transparency in Stakeholder Funding
• 1Guiding Principles
• 2Privacy of Patient Information
• 3Transparency
• 4Members’ Employees
• 5Scientific Exchanges
• 6Business Meetings and Discussions
• 7Retaining the Services of a Stakeholder
• 8Consultant Meetings
• 9Learning Programs for Health Care Professionals
• 10Conferences and Congresses
• 11Displays
• 12Provision of Funding
• 13Loan of Medical Equipment
• 14Patient Support Programs and Medical Practice Activities
• 15Service-Oriented Items
• 16Clinical Evaluation Packages (“Samples”)
• 17Market Research
• 18Post Registration Clinical Studies
• 19Enforcement